Prof. Sammar fathy Elhabal | drug delivery | Best Researcher Award

Prof. Sammar fathy Elhabal | drug delivery | Best Researcher Award

Prof. Sammar fathy Elhabal, Modern University MTΔ°, Egypt

Sammar Fathy Ibrahim Elhabal, Ph.D., is a distinguished academic and researcher in the field of pharmaceutics, specializing in advanced drug delivery systems and nanotechnology. With a Ph.D. from Cairo University, Egypt, her expertise spans controlled release, ophthalmic and oral drug delivery, and nanofiber-based formulations. Dr. Elhabal has made significant contributions to various high-impact journals and is passionate about enhancing healthcare through innovative drug delivery technologies. She has held various academic positions and is committed to mentoring the next generation of pharmacists. πŸŒŸπŸ’ŠπŸ“š

Professional Profile:

Scopus

Suitability for the Best Researcher Award

Dr. Sammar Fathy Ibrahim Elhabal is an exemplary candidate for the Best Researcher Award, with a well-rounded and impressive career in pharmaceutics, particularly in the field of advanced drug delivery systems and nanotechnology. Her academic qualifications, impactful research contributions, leadership in education, and dedication to advancing healthcare make her a standout scholar in her field.

Education & Experience

  • Ph.D. in Pharmaceutics, Faculty of Pharmacy, Cairo University, 2021 πŸŽ“
  • M.Sc. in Pharmaceutics, Faculty of Pharmacy, Tanta University, 2018 πŸŽ“
  • B.Sc. in Pharmaceutical Sciences (Honor), October 6 University, 2013 πŸŽ“
  • Lecturer, Pharmaceutics Department, Modern University for Technology & Information (MTI), Cairo, Egypt πŸ“š
  • Area Manager, 19011 Pharmacies Chain, Giza, Egypt πŸ₯
  • Branch Manager, Roshdy Pharmacies Chain, Giza, Egypt πŸ₯

Professional Development

Dr. Sammar Fathy Elhabal has a strong background in teaching, research, and leadership within the pharmaceutical field. She has been an academic advisor and a member of various committees at the Modern University for Technology & Information (MTI). Dr. Elhabal has collaborated with faculty to develop new course material, facilitated professional development, and mentored students and junior faculty. Additionally, her commitment extends to research, particularly in drug delivery systems and nanotechnology. She is an active contributor to academic communities through her publications and research collaborations. πŸ“šπŸ‘©β€πŸ«πŸ’‘

Research Focus

Dr. Elhabal’s research is focused on advanced drug delivery systems, with a special emphasis on nanotechnology. She explores areas such as nanofibers, ophthalmic and oral drug delivery, controlled release, and targeted drug delivery. Her work in nanotechnology, including nanofiber-based systems, aims to improve therapeutic outcomes through more efficient drug release and delivery methods. Dr. Elhabal is also investigating green, eco-friendly nanoparticles for use in medical formulations. Her work aims to make drug delivery more effective, sustainable, and patient-friendly. πŸ’‰πŸ”¬πŸŒ±

Awards & Honors

  • Best Publication Award, International Journal of Nanomedicine, 2024 πŸ†
  • Excellence in Research Award, Modern University for Technology & Information, 2023 πŸ…
  • Outstanding Lecturer Award, Faculty of Pharmacy, Tanta University, 2019 🌟
  • Research Excellence Award, Cairo University, 2018 πŸ…

Publication Top Notes:

  • πŸ“„ Potential application of sucrose acetate isobutyrate, and glyceryl monooleate for nanonization and bioavailability enhancement of rivaroxaban tablets
  • πŸ“„ Enhanced Antibacterial Activity of Clindamycin Using Molecularly Imprinted Polymer Nanoparticles Loaded with Polyurethane Nanofibrous Scaffolds for the Treatment of Acne Vulgaris
    • Cited by: 2
  • πŸ“š ANTI-OBESITY NUTRACEUTICALS: INSIGHTS INTO MECHANISMS OF ACTION AND POTENTIAL USE OF BIOCOMPATIBLE NANOCARRIERS FOR DELIVERY
    • Cited by: 1
  • πŸ“„ Formulation, optimization and evaluation of ocular gel containing nebivolol Hcl-loaded ultradeformable spanlastics nanovesicles: In vitro and in vivo studies
    • Cited by: 10
  • πŸ“„ FORMULATION AND STABILITY EVALUATION OF ANTI-OBESITY NUTRACEUITCAL BLEND OF WHITE KIDNEY BEAN EXTRACT (PHASEOLUS VULGARIS L.), PROPOLIS ETHANOLIC EXTRACT AND CRPIC3